HIV Infection in Homosexual and Bisexual Men - Tabular View

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

HIV Infection in Homosexual and Bisexual Men

This study is ongoing, but not recruiting participants.

Study NCT00046280. Last updated on August 7, 2008. Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

This Tabular View shows the required WHO registration data elements as marked by ^†

Descriptive Information Fields
Brief Title ^†	HIV Infection in Homosexual and Bisexual Men
Official Title ^†
Brief Summary	This is a comprehensive observational study of HIV infection in homosexual and bisexual men.
Detailed Description	The Multicenter AIDS Cohort Study (MACS) provides important information about the changing nature of HIV-mediated disease progression, the impact of antiretroviral treatment, the nature of HIV pathogenesis, and viral and host genetic factors. This study will also assess the long-term patterns of therapy use and risk-taking behaviors. Patients will have study visits every 6 months. The visits will include interviews, specimen collection, and a physical examination.
Study Phase
Study Type ^†	Observational
Study Design ^†	Prospective
Primary Outcome Measure ^†
Secondary Outcome Measure ^†
Condition ^†	HIV Infections
Intervention ^†
MEDLINE PMIDs	14999110, 1877593, 7585150, 7903022, 8931213, 8614118, 9451969, 9182471, 10720507, 11273215, 11581102, 9809730, 11371688, 11404539, 11176272, 11160967, 11943695, 7697447, 12461420, 10969345, 14742283, 12799406, 14507605, 12939443, 12815503, 12493258, 12138349, 11948473, 11752157, 11602040, 11502933, 16044017, 16135508, 15735452, 15405677, 16260908, 16177829
Links	Click here for the MACS homepage. Haga clic aquí para ver información sobre este ensayo clínico en español.

Recruitment Information Fields
Recruitment Status ^†	Active, not recruiting
Enrollment ^†	1100
Start Date ^†
Completion Date
Eligibility Criteria ^†	Inclusion Criteria: HIV negative, or HIV positive and no history or current use of highly active antiretroviral therapy (HAART), or HIV positive HAART recipient with documentation of HAART initiation, no AIDS diagnosis prior to HAART initiation, and a CD4 cell count and HIV-1 RNA measurement within 6 months prior to first HAART use. Sexual intercourse with men or at least 5 male or female partners in the 5 years prior to enrollment. Exclusion Criteria: Injection drug use within 1 year of enrollment. Perinatally acquired HIV infection.
Gender	Male
Ages	18 Years and older
Accepts Healthy Volunteers	No
Contacts ^††
Location Countries ^†	United States

Administrative Information Fields
NCT ID ^†	NCT00046280
Organization ID	MACS
Secondary IDs ^††
Study Sponsor ^†	National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators ^††
Investigators ^†
Information Provided By	National Institute of Allergy and Infectious Diseases (NIAID)
Verification Date	November 2005
First Received Date ^†	September 24, 2002
Last Updated Date	August 7, 2008

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.